Diabetes trailnet: Natural history study of the development of type 1 diabetes

The Type 1 Diabetes TrialNet, an international research program, is screening relatives of people with type 1 diabetes to find out if these family members are at risk of developing diabetes.

The screening test is the first phase of the TrialNet Natural History Study of the Development of Type 1 Diabetes. (ClinicalTrials.gov Identifier NCT00097292).

Screening involves either one or two blood tests to see if diabetes-related autoantibodies are present. Autoantibodies are proteins made by the body's immune system which indicate that the cells in the pancreas that make insulin may be damaged. There is no cost to you for these screening tests. You will be notified of results within 4–6 weeks after your blood sample is received.

If your or your child's test shows evidence of autoantibodies, you have the option of volunteering to be monitored every 6 months for the development of type 1 diabetes.

To be eligible to participate, you must be:

• between 1–45 years of age, and
• you must be a first-degree relative (sibling, parent or child) of a person with type 1 diabetes.
  

You may also participate if you are:

• 20 years of age or less and
• are a second-degree relative (niece, nephew, aunt, uncle, cousin, or half-siblings) of a person with type 1 diabetes.

For more information, please contact Susan Baynham at 604-875-2345, local 6658 or visit the TrialNet website.